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50S Abstracts June Supplement 2014Conclusions: VSI can be a useful new parameter to di-
agnose CHS in patients after undergoing CEA under gen-
eral anesthesia. However, this observation needs to be
validated by other larger studies.
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Objectives: The aim of this study is to analyze read-
missions and their associated hospital costs after common
vascular surgeries at a single institution.
Methods: Patients undergoing open or endovascular
abdominal aortic aneurysm repair, aortoiliac revasculariza-
tion, or infrainguinal revascularization from 2010 through
2012 were retrospectively evaluated. We compared 30-day
and 90-day readmission rates and costs by procedure
group, tabulated reasons for readmission, and identiﬁed
preoperative and perioperative risk factors by univariate
analysis. Parametric or nonparametric methods were used
as appropriate.
Results: We analyzed 219 cases, which had a 30-day
readmission rate of 16.9% and 90-day readmission rate of
27.4% (Table). Median readmission costs were $10,700.
The most frequent reasons for readmissions related to
the procedure were surgical wound complications (60%),
graft occlusion (14%), and renal insufﬁciency/failure
(8%), bleeding (5%), and endoleak (5%). Risk factors for
readmission included hyperglycemia on discharge, periop-
erative transfusion, preoperative open wound, dialysis,
chronic obstructive pulmonary disease, and functional
dependency.
Conclusions: Vascular surgery readmissions occur
at a rate of 27.4% at 90 days and have an associated me-
dian cost of $10,700 per readmission comprising an
additional 38.6% beyond the index admission cost. Pre-
vention of surgical wound complications and vigilance
to ensure that open wounds and chronic comorbidities
are well managed as patients leave the hospital should
be the focus of interventions aiming at reducing






costs ($000s)#30 day #90 day
eAAA 38 14 21 18
oAAA 42 13 13 1.4
eAIR 18 19 25 23
oAIR 29 29 29 3.3
eIIR 18 9 32 9.7
oIIR 25 24 41 10
Total 27.7 16.9 27.4 10.7Author Disclosures: D. L. Davenport: Nothing to
disclose; S. El-Maraghi: Nothing to disclose; N. T. Orr:
Nothing to disclose; E. S. Xenos: Nothing to disclose.
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Objectives: Iliac injury is a devastating and potentially
avoidable complication of endovascular aortic intervention.
To our knowledge, this study is the ﬁrst investigation of de-
mographic, anatomic, and device factors related to iliac
injury in vascular surgery patients.
Methods: We retrospectively examined 1859 endo-
vascular aortic interventions and found 42 iliac injuries,
including 21 ruptures. Demographic, anatomic, and device
data were extracted from these patients and a cohort of 200
case-matched control patients derived from the group of
uninjured patients. Anatomic data includes centerline and
straight distance measurement of the iliac system from
the aortic bifurcation to the inguinal ligament. The ratio
of the two (“tortuosity index”) was calculated. Additional
data includes midpoint and narrowest diameters in the iliac
system along with the most acute angle. Each measure-
ment was taken for the side through which the main
body was introduced (“device side”) and the contralateral
side.
Results: Demographic factors associated with injury
were female gender (P < .001) and non-Caucasian race
(P ¼ .028). None of the examined comorbidities were
associated with iliac injury. Increasing sheath size was asso-
ciated with injury (P < .001). Device-side anatomic factors
associated with injury were decreasing iliac midpoint (P ¼
.002) and narrowest diameters (P < .001). Contralateral-
side anatomic variables associated with injury were iliac
centerline distance (P ¼ .030), decreasing midpoint
(P < .001), narrowest diameters (P < .001), and angularity
(P ¼ .036). Injury is associated with inpatient death
(P < .001), with iliac rupture conferring an odds ratio of
15.3 (P < .001).
Conclusions: Iliac injury is associated with death on
the index admission. Female gender, non-Caucasian race,
large sheath sizes, and iliac occlusive disease and angularity
are associated with iliac injury. These ﬁndings should be
prospectively evaluated along with interventions to reduce
injury.
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National Trends in Surgical Site Infections in Open
Vascular Procedures: Has SCIP Made an Impact?
Anahita Dua1, Sapan S. Desai2, SreyRam Kuy3, Charles
E. Edmiston4, Cheong J. Lee3. 1Center for
Table. Rate of surgical site infection for AAA, CEA, peripheral bypass from 2000-2010 using the NIS
2000 2001 2002 2003 2004 2005 2007 2008 2009 2010
SSI 446 384 435 412 369 340 364 328 300 251
CEA Total 20,230 19,700 19,539 18,062 16,558 15,183 13,999 14,193 13,354 12,311
% 2.2 1.9 2.2 2.3 2.2 2.2 2.6 2.3 2.2 2.0
SSI 51 52 60 57 50 41 45 20 42 27
AAA (P < .05) Total 7572 5563 4958 4698 4156 3570 2616 2597 2302 1782
% 0.7 0.9 1.2 1.2 1.2 1.1 1.7 0.8 1.8 1.5
SSI 42 35 48 44 37 48 36 39 29 19
Bypass Total 30,277 30,190 30,979 29,440 26,285 25,188 24,628 24,541 22,592 19,665
% 0.1 0.1 0.2 0.1 0.1 0.2 0.1 0.2 0.1 0.1
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Objectives: The Surgical Care Improvement Project
(SCIP) is a national initiative to reduce surgical complica-
tions, including postoperative surgical site infection (SSI),
through protocol-driven antibiotic usage. This study aimed
to determine the impact SCIP guidelines had on SSIs after
open vascular procedures.
Methods: A retrospective analysis was completed us-
ing the National Inpatient Sample (NIS) using ICD-9
diagnosis codes to capture patients who underwent elective
carotid endarterectomy (CEA), elective open repair of
abdominal aortic aneurysms (AAA), and peripheral bypass
who developed surgical site infections (SSIs). The pre-
SCIP era was deﬁned as 2000 to 2005 and post-SCIP
was deﬁned as 2007 to 2010. The year 2006 was excluded
because this was the transition year in which the SCIP
guidelines were implemented. Analysis of variance and c2
testing were used for statistical analysis.
Results: The incidence of SSI was higher in the post-
SCIP era for open AAA repairs. For those who underwent
CEA or peripheral bypass, there was no difference in SSI
rates in the pre-SCIP to post-SCIP era (Table). There
were no signiﬁcant differences between demographics or
in-hospital mortality between groups.
Conclusions: Implementation of SCIP guidelines has
made no signiﬁcant impact on the incidence of SSI in
open vascular operations; rather, an increase in SSI rates
in open AAA repairs was observed.
Author Disclosures: S. S. Desai: Nothing to disclose; A.
Dua: Nothing to disclose; C. E. Edmiston: Nothing to
disclose; S. Kuy: Nothing to disclose; C. J. Lee: Nothing
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Objectives: Pseudoaneurysms (PA) are a well-recog-
nized complication of percutaneous angiographic proce-
dures. Ultrasound-guided thrombin injection is currently
the preferred treatment modality. This study was under-
taken to evaluate our experience with postprocedure PA
(PPPA).
Methods: A retrospective study was performed of all
patients who developed a PPPA between March 2004
and January 2013. Data were obtained from our prospec-
tively maintained noninvasive vascular laboratory data
bank.
Results: We identiﬁed 167 patients (80 men) with
PPPA. Mean age was 66 years. PPPA developed after
diagnostic coronary angiography in 65 (38%), coronary
angioplasty in 63 (37%), peripheral vascular interven-
tions in 25 (14.7%), and other access procedures in 13
(7.6%). Mean PPAA diameter was 2.8 6 1.8 cm.
Thrombin was injected in 142 PPPAs under ultrasound
guidance. There were 12 failures (8.5%), of which 10
(83%) responded to reinjection and two (17%) required
operative management. Failures were associated with
increasing aneurysm diameter (odds ratio, 2.23; 95%
conﬁdence interval, 1.25-3.96; P ¼ .006) and end-stage
renal disease (odds ratio, 1.15; 95% conﬁdence interval,
1.09-1.78; P ¼ .013). There were two episodes of
thrombus formation in the femoral artery: one resolved
with anticoagulation alone and the other required
thrombectomy. Treatment of the 25 PPPA not injected
included ultrasound-guided compression in seven
(25%), surgical repair in 10 (46.5%), and observation in
eight (28.5%).
Conclusions: Percutaneous ultrasound-guided thrombin
injection is an effective and safe treatment for PPPA. Failure
rates are low and associated with larger aneurysm size and
end-stage renal disease.Author Disclosures: P. Balraj: Nothing to disclose;
F. Esmael: Nothing to disclose; L. Kabbani:
Nothing to disclose; E. Karamanos: Nothing to
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